TrialClinical drug investigation2014

Comparative pharmacokinetics and bioavailability of gemifloxacin administered as an intravenous 200 mg formulation or an oral 320 mg tablet.

Mi Jo Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.